Clay B. Siegall

2011

In 2011, Clay B. Siegall earned a total compensation of $4.9M as President and CEO at Seattle Genetics, a 52% increase compared to previous year.

Compensation breakdown

Bonus$519
Non-Equity Incentive Plan$807,400
Option Awards$2,219,546
Salary$657,500
Stock Awards$1,200,380
Other$7,830
Total$4,893,175

Siegall received $2.2M in option awards, accounting for 45% of the total pay in 2011.

Siegall also received $519 in bonus, $807.4K in non-equity incentive plan, $657.5K in salary, $1.2M in stock awards and $7.8K in other compensation.

Rankings

In 2011, Clay B. Siegall's compensation ranked 1,129th out of 10,747 executives tracked by ExecPay. In other words, Siegall earned more than 89.5% of executives.

ClassificationRankingPercentile
All
1,129
out of 10,747
90th
Division
Manufacturing
420
out of 3,958
89th
Major group
Chemicals And Allied Products
96
out of 1,031
91st
Industry group
Drugs
55
out of 779
93rd
Industry
Biological Products, Except Diagnostic Substances
5
out of 159
97th
Source: SEC filing on April 7, 2014.

Siegall's colleagues

We found four more compensation records of executives who worked with Clay B. Siegall at Seattle Genetics in 2011.

2011

Eric Dobmeier

Seattle Genetics

Chief Operating Officer

2011

Thomas Reynolds

Seattle Genetics

Chief Medical Officer

2011

Todd Simpson

Seattle Genetics

Chief Financial Officer

2011

Morris Rosenberg

Seattle Genetics

EVP, Process Sciences

News

You may also like